Evidence map›Paper›PMID 32819978›Full record

ArticleBMJ open diabetes research & care2020

Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9.

Enzo Bonora, Maddalena Trombetta, Marco Dauriz, Daniela Travia, Vittorio Cacciatori, Corinna Brangani, Carlo Negri, Fabrizia Perrone, Isabella Pichiri, Vincenzo Stoico and 8 more

4 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01526720 unknown statusnot on this map

The Verona Newly Diagnosed Type 2 Diabetes Study. Construction of a Biobank of Diabetes Related Genotypes and Phenotypes

TypeobservationalSponsorUniversita di VeronaRan2003 to 2020Enrolled1,500ConditionsType 2 Diabetes Mellitus
NCT06518486 nacompletednot on this mapstarted 2024, after this paper: background citation

The Effectiveness of Foot-Ankle Exercise and Walking Exercise on Foot Neuropathy, Stress, Quality of Life, Blood Sugar Markers, Blood Pressure, Ankle-Brachial Index, and BMI Among Diabetes Mellitus Patients

TypeinterventionalSponsorTaipei Medical UniversityRan2024 to 2025Enrolled375ConditionsDiabetic Foot, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Diabetes Type 2ArmsFoot-ankle exercise, Walking exercise, Usual care and health education
NCT06706609 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Classification of Adult-onset Diabetes in Five Subgroups in Pakistani Population

TypeobservationalSponsorGetz PharmaRan2025 to 2025Enrolled394ConditionsDiabetes Mellitus, Diabetes Mellitus, Adult-Onset, Diabetes Mellitus Type 1 and 2
NCT07270328 nacompletednot on this mapstarted 2024, after this paper: background citation

A Pilot Study of Feasibility and Exploratory Study for a Definitive Randomised Controlled Trial of Foot-Ankle Versus Walking Exercises in Patients With Diabetes Mellitus: Effects on Neuropathy, Stress, and Quality of Life

TypeinterventionalSponsorTaipei Medical UniversityRan2024 to 2024Enrolled108ConditionsDiabete Mellitus, Diabete Type 2, Diabetic Peripheral Neuropathy, Diabetic FootArmsFoot-ankle exercise group, Walking exercise group, Control group
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Therapeutic Inertia in an Insured Population with Type 2 Diabetes in the United States: A Retrospective Cohort Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Enzo Bonora *Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy enzo.bonora@univr.it.ORCID 0000-0003-1074-5164
Maddalena Trombetta *Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy.
Marco DaurizDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy.
Daniela TraviaDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Vittorio CacciatoriDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Corinna BranganiDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Carlo NegriDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Fabrizia PerroneDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Isabella PichiriDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Vincenzo StoicoDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Giacomo ZoppiniDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy.ORCID 0000-0003-1085-554X
Elisabetta RinaldiDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy.
Giuliana Da PratoDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy.
Maria Linda BoselliDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy.
Lorenza SantiDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy.
Federica MoschettaDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy.
Monica ZardiniDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona, Verona, Italy.
Riccardo C BonadonnaDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
University of Verona · ITAzienda Ospedaliera Universitaria Integrata Verona · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe explored the presence of chronic complications in subjects with newly diagnosed type 2 diabetes referred to the Verona Diabetes Clinic. Metabolic (insulin secretion and sensitivity) and clinical features associated with complications were also investigated. RESEARCH DESIGN AND

methodsThe comprehensive assessment of microvascular and macrovascular complications included detailed medical history, resting ECG, ultrasonography of carotid and lower limb arteries, quantitative neurological evaluation, cardiovascular autonomic tests, ophthalmoscopy, kidney function tests. Insulin sensitivity and beta-cell function were assessed by state-of-the-art techniques (insulin clamp and mathematical modeling of glucose/C-peptide curves during oral glucose tolerance test).

resultsWe examined 806 patients (median age years, two-thirds males), of whom prior clinical cardiovascular disease (CVD) was revealed in 11.2% and preclinical CVD in 7.7%. Somatic neuropathy was found in 21.2% and cardiovascular autonomic neuropathy in 18.6%. Retinopathy was observed in 4.9% (background 4.2%, proliferative 0.7%). Chronic kidney disease (estimated glomerular filtration rate <60 mL/min/1.73 m

conclusionsDespite a generally earlier diagnosis for an increased awareness of the disease, as many as ~50% of patients with newly diagnosed type 2 diabetes had clinical or preclinical manifestations of microvascular and/or macrovascular disease. Insulin resistance might play an independent role in macrovascular disease. TRIAL REGISTRATION NUMBER: NCT01526720.

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceBlood GlucoseHumansMalePrevalenceRisk FactorsBlood Glucosediabetes complicationsdiabetes mellitusinsulin resistanceinsulin secretiontype 2

Identifiers

PMID32819978
PMCPMC7443259
OpenAlexW3081196030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.